Monitoring cell fates

July 27, 2016 by Isabelle Fol
Blood stem cells in the bone marrow give rise to both red and white blood cells. Credit: Colourbox/ETH Zurich

An international team of researchers led by ETH scientists has been studying the factors influencing the development of different blood cells. Their research shows that certain molecular mechanisms are not as relevant as previously assumed. This finding helps to improve our understanding of diseases such as leukemia and anemia.

In biological terms, a cell is the smallest functional entity of living organisms. The human body contains an enormous number of cells: somewhere in the region of 10 to 100 trillion, depending on a person's size and weight. Most of these cells perform specific functions in the body and are called differentiated cells. Stem cells, on the other hand, are able to continuously divide to produce more and differentiated cells, thereby providing an endless supply of . Certain cells in the body have a relatively short life span. For example, many white blood cells (leucocytes) and (thrombocytes) die within a few hours to a couple of days, while red blood cells (erythrocytes) survive around four months.

Stem cell regeneration

Stem cells in the bone marrow thus produce millions of new blood cells every second. These stem cells are multipotent, which means they can generate all types of specialised blood cell with different functions: , responsible for oxygen transport, that are part of the body's immune defence system, and blood platelets which play a key role in blood-clotting. Exactly how stem cells develop into different cell types is still only partly understood. The process of differentiation - in other words, the decision as to which type of cell will be produced - depends on a number of different external and internal factors.

Timm Schroeder, Professor at the ETH Zurich Department of Biosystems Science and Engineering based in Basel, and his colleagues are studying the factors that play a role in the development of the individual blood cells. "The regulation of plays a vital role in maintining the normal process of blood formation", explains Professor Schroeder. "If this system starts to malfunction, it can lead to life-threatening diseases such as anaemia and leukaemia. We therefore need to have a better understanding of the molecular mechanism involved in this regulation."

Observation at the molecular level

The cell biologist and his team are analysing how stem cells differentiate into the different types of blood cell and how molecules in the cell nucleus (transcription factors) control this complex process. Working with the Helmholtz Zentrum Munich (German Research Centre for Environmental Health), they have developed an innovative microscopy technique for observing cells - cutting-edge equipment that is only found in very few of the world's stem cell research laboratories.

The two proteins GATA1 and PU.1 have been a particular focus of the researcher's attention. They play an important role in the differentiation of blood cells, explains Timm Schroeder. "They are transcription factors capable of activating or disabling comprehensive genetic programs with many target genes. This makes them powerful regulators of cell fates."

Promising potential

Using time-lapse microscopy, the researchers could observe living with unprecedented precision as they differentiated, while also quantifying the two proteins GATA1 and PU.1. "For decades it was thought that these two were responsible for making the lineage decisions for stem . Now we are able to show that this is not the case, but that other mechanisms must be responsible for these decisions", explains Professor Schroeder. Research now needs to concentrate on other molecular mechanisms in order to understand the extremely complex process of blood stem cell differentiation.

Blood diseases such as leukaemia are severe disorders of the blood system. To improve our understanding of such diseases in future and to come up with effective treatments, we need to know exactly how the individual are created. A foundation stone for this research has now been laid at ETH Zurich.

More information: Philipp S. Hoppe et al, Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios, Nature (2016). DOI: 10.1038/nature18320

Provided by: ETH Zurich

Explore further

Font size

A

A

Select topic

Switch to?

Share to?


loading...




loading...